Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO - Trial NCT04548284
Access comprehensive clinical trial information for NCT04548284 through Pure Global AI's free database. This Phase 3 trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 142 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sun Yat-sen University
Timeline & Enrollment
Phase 3
May 01, 2021
Dec 01, 2023
Primary Outcome
Change of Clinical Activity Score (CAS) score,Change of NOSPECS score
Summary
The purpose of this study is to determine whether periorbital injection of glucocorticoid is
 effective and necessary in the treatment of mild TAO.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04548284
Non-Device Trial